DUBAI, United Arab Emirates - Investors in the Abraaj Growth Markets Health Fund (“AGHF” or “the Fund”) have today underlined their strong commitment to AGHF by announcing the appointment of global consulting firm, AlixPartners, to oversee the separation of AGHF from the Abraaj Group to ensure the long term success of the Fund in delivering accessible, affordable and quality healthcare in developing countries.
AGHF is a US$1 billion investment fund with a mandate to provide affordable, high-quality healthcare to under-served low and middle-income patients throughout Sub-Saharan Africa and South Asia, with performance measured by both financial returns and development impact metrics. The Fund is now in the process of separating from the Abraaj Group to ensure continuity and build a stable platform for the future.
The recently announced appointment of provisional liquidators over Abraaj Holdings and Abraaj Investment Management Limited (“AIML”), the investment manager of the Fund, does not impact the day to day operations of the Fund’s portfolio. AlixPartners is now working alongside the Fund’s senior operational team and the provisional liquidators of AIML and supporting the search for a permanent replacement investment manager to manage the Fund and continue its vital work.
Simon Appell from AlixPartners commented:
“The Abraaj Growth Markets Health Fund is helping to deliver accessible, affordable and quality care for low and middle-income people in 10 of the largest cities in Sub Saharan Africa and South Asia, and we want to see that continue. We’re working with the Fund’s investors, its senior operational team and the provisional liquidators as part of ongoing discussions with several potential replacement managers for the Fund who will continue to support its investee businesses.
“We are delighted that investors continue to support and finance the Fund as it goes through this transition and thank management, portfolio company founders, and advisors for their assistance and support of the Fund’s mission.”
Investors in the Fund include the Bill & Melinda Gates Foundation, CDC Group plc, International Finance Corporation, Medtronic, OPIC, Philips, and Proparco.
About Abraaj Growth Markets Health Fund
The Abraaj Growth Markets Health Fund believes in the power of private capital to bring solutions to some of the world’s most pressing challenges. Delivering accessible, affordable and quality care is the centrepiece of our healthcare strategy. The Fund is measured by both financial returns and impact metrics and is firmly targeted at Sustainable Development Goal 3, to bring healthy lives to the communities it serves.
Partnering with NGOs, industry and governments our aim is to transform healthcare delivery systems for low and middle-income segments of the population in 10 of the largest cities in Sub Saharan Africa and South Asia.
To date the Fund has ownership interests in 26 hospitals, 17 clinics and 32 diagnostics centres in India, Pakistan and Kenya and is in the process of entering the market in Nigeria.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180816005528/en/
*Source: AETOSWire
Contacts
AlixPartners
Robin Knight
+44-7799-477733
Rknight@alixpartners.com
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
